CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Vilacto Bio Inc.  (ZFLO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $ 0.00
Open: $ 0.00 52 Wk Low: 0.00
You need to upgrade your Flash Player


 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 90
 Employees 1
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) -0
Vilacto Bio Inc.
we changed our name from Zlato, Inc. to Vilacto Bio Inc. With our new name, majority shareholder and management, we have decided to abandon our former business plan of marketing electronic medical record software, and opted for a new business direction. We are now a biotech company based in Denmark that has acquired a license to a patented molecule, known as the Lactoactive molecule, that has in numerous studies demonstrated above average effect in treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. We aim to further develop our Lactoactive molecule for the purpose of increasing the quality of our retail and medical skin cream products as well as developing products for medical applications.

We are currently marketing a line of our skin care products on our website at www.vilacto.com. These products include, lotions, skin care creams and gels, lip balms, foot creams and oils, and similar items.



ZFLO is expected to report next financial results on February 07, 2019.
 

Vilacto Bio's Segments
 
 
  Company Estimates  
  Revenue Outlook
Vilacto Bio does not provide revenue guidance.

Earnings Outlook
Vilacto Bio Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion

First Internet Bancorp

First Internet Bancorp announced third quarter operating income of $7.031 millions

In the third quarter company failed to grow earnings, despite strong Revenue growth of 18.68 % to $17.08 millions, earnings remained unchanged at $0.61 per share, year on year.

Trade Desk, Inc.

Impressive Quarter

Company's third quarter income surged by 91.3 % to $0.44 per share compared to a year ago on growing Sales of 49.63 % to $118.83 millions.

Golden Entertainment, Inc.

Slipped into Red, Sales very Strong

Golden Entertainment, Inc announced earnings per share of $-0.11 and Sales of $216.54 millions in the third quarter, Company's slipped into loss per share, versus $0.36 eps, earned in the same quarter a year ago, although Golden Entertainment, Inc saw it's Sales rise by 94.18 % in the same period.

Ultra Petroleum Corp.

Ultra Petroleum Corp announced third quarter operating income of $77.65 millions

third quarter was profitable despite lower revenues, turn a round to $0.09 per share compare to $-1.67 loss, while Sales declined by -7.37 % to $203.78 millions from $219.98 millions, compare to third quarter a year ago.

Tetraphase Pharmaceuticals Inc

Tetraphase Pharmaceuticals Inc announced third quarter operating deficit of $-19.995 millions

In the third quarter Tetraphase Pharmaceuticals Inc lost money of $-0.37 per share compare to $-0.63 a year ago and increased losses from $-0.18 per share from the previous quarter.

Sales fell sharply by -71.7 % to $1.15 millions from $4.07 millions in the same quarter a year ago and sequentially Sales advanced by -90.06 % from $11.58 millions.






You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FCUV's Profile

Stock Price

FCUV's Financials

Business Description

Fundamentals

Charts & Quotes

FCUV's News

Suppliers

FCUV's Competitors

Customers & Markets

Economic Indicators

FCUV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071